EnPro Reports Fourth Quarter and Full Year 2021 Results, Introduces 2022 Guidance
EnPro Industries, Inc. (NYSE: NPO) reported fourth quarter sales of $280.8 million, a 1.7% increase, while full year sales reached $1.14 billion, up 6.3%. Income from continuing operations for Q4 was $102.4 million, recovering from a loss of $8.9 million a year prior. Diluted EPS for Q4 was $4.92, compared to a loss per share of $0.43 previously. The company completed the acquisition of NxEdge and divested its CPI unit. For 2022, EnPro anticipates low double-digit revenue growth, adjusted EBITDA between $263-$275 million, and diluted EPS of $6.70-$7.25.
- Sales increased 1.7% to $280.8 million in Q4 2021 and 6.3% to $1.14 billion for the full year.
- Income from continuing operations improved to $102.4 million in Q4 2021 from a loss of $8.9 million.
- Diluted EPS rose to $4.92 in Q4 2021 from a loss per share of $0.43 the previous year.
- Achieved adjusted EBITDA of $208.4 million for the full year, up 23.8%.
- Adjusted EBITDA decreased 0.8% to $47.7 million in Q4 2021.
- Corporate expenses rose to $26.9 million in Q4, up from $10.6 million year over year.
Fourth Quarter and Full Year 2021 Highlights
(All results reflect comparisons to the respective prior-year period unless otherwise noted)
-
Sales of
increased$280.8 million 1.7% and organic sales increased10.4% for the quarter; for the year, sales of increased$1.14 billion 6.3% and organic sales increased14.4%
-
Income from continuing operations attributable to
EnPro Industries, Inc. for the quarter was , compared to a loss of$102.4 million ; income from continuing operations was$8.9 million for the year, compared to a loss of$177.2 million $23.7 million
-
Adjusted EBITDA* decreased
0.8% to and adjusted EBITDA margin decreased 40 bps to$47.7 million 17.0% for the quarter; adjusted EBITDA* increased23.8% to and adjusted EBITDA margin increased 260 bps to$208.4 million 18.3% for the year
-
Diluted earnings per share from continuing operations attributable to
EnPro Industries, Inc. was for the quarter, compared to a diluted loss per share of$4.92 ; diluted earnings per share from continuing operations was$0.43 for the year, compared to a diluted loss per share of$8.53 $1.15
-
Adjusted diluted earnings per share* decreased
0.8% to for the quarter versus$1.23 in the prior-year period; adjusted diluted earnings per share* increased$1.24 36.4% to in 2021 versus$5.55 in the prior-year$4.07
-
Completed acquisition of
NxEdge , a leading provider of vertically integrated capabilities across the semiconductor value chain, and the divestiture ofCompressor Products International, Inc. (CPI) in December
-
Introducing guidance for 2022: revenue growth in the low double-digit range, adjusted EBITDA of
to$263 million , and adjusted diluted earnings per share from continuing operations of$275 million to$6.70 $7.25
"EnPro delivered solid fourth quarter results capping another transformational year for our company,” said
Financial Highlights
(Amounts in millions except per share data and percentages)
|
Quarters Ended |
|
Years Ended |
||||||||||||||
|
2021 |
2020 |
Change |
|
2021 |
2020 |
Change |
||||||||||
|
$ |
280.8 |
|
$ |
276.0 |
|
1.7 |
% |
|
$ |
1,141.8 |
|
$ |
1,074.0 |
|
6.3 |
% |
Income (Loss) from Continuing Operations Attributable to |
$ |
102.4 |
|
$ |
(8.9 |
) |
nm |
|
$ |
177.2 |
|
$ |
(23.7 |
) |
nm |
||
Diluted Earnings (Loss) Per Share Attributable to |
$ |
4.92 |
|
$ |
(0.43 |
) |
nm |
|
$ |
8.53 |
|
$ |
(1.15 |
) |
nm |
||
Adjusted Income from Continuing Operations Attributable to |
$ |
25.5 |
|
$ |
25.4 |
|
0.4 |
% |
|
$ |
115.3 |
|
$ |
83.9 |
|
37.4 |
% |
Adjusted Diluted Earnings Per Share* |
$ |
1.23 |
|
$ |
1.24 |
|
(0.8 |
) % |
|
$ |
5.55 |
|
$ |
4.07 |
|
36.4 |
% |
Adjusted EBITDA* |
$ |
47.7 |
|
$ |
48.1 |
|
(0.8 |
) % |
|
$ |
208.4 |
|
$ |
168.3 |
|
23.8 |
% |
Adjusted EBITDA Margin* |
|
17.0 |
% |
|
17.4 |
% |
|
|
|
18.3 |
% |
|
15.7 |
% |
|
*Non-GAAP measure. See the attached schedules for adjustments and reconciliations to GAAP numbers.
Fourth Quarter 2021 Consolidated Results
Sales of
Corporate expenses of
Income from continuing operations attributable to
Adjusted EBITDA margin of
Fourth Quarter 2021 Segment Highlights
Sealing Technologies - Safeguarding critical environments with unique applications in diverse end markets
Garlock, STEMCO, and
|
Quarters Ended |
|
Years Ended |
||||||||||||||
(Amounts in millions except percentages) |
2021 |
2020 |
Change |
|
2021 |
2020 |
Change |
||||||||||
Sales |
$ |
143.9 |
|
$ |
154.7 |
|
(7.0 |
)% |
|
$ |
599.8 |
|
$ |
636.7 |
|
(5.8 |
)% |
Adjusted Segment EBITDA |
$ |
30.6 |
|
$ |
34.9 |
|
(12.3 |
)% |
|
$ |
141.4 |
|
$ |
131.0 |
|
7.9 |
% |
Adjusted Segment EBITDA Margin |
|
21.3 |
% |
|
22.6 |
% |
|
|
|
23.6 |
% |
|
20.6 |
% |
|
-
Due to the impact of divestitures, sales decreased
7.0% versus the prior-year period. Excluding the impact of foreign exchange translation and divested businesses, sales increased12.0% versus the prior-year period, driven primarily by strong demand in heavy-duty truck, aerospace, nuclear and food & pharma markets. -
Adjusted segment EBITDA decreased
12.3% versus the prior-year period, due to businesses divested in 2020 and 2021, inflationary pressures from raw materials, and labor and freight costs, largely concentrated in our heavy-duty truck market, partially offset by pricing initiatives and leverage from organic sales growth. Excluding the impact of foreign exchange translation and divestitures, adjusted segment EBITDA increased3.0% compared to the prior-year period.
Advanced Surface Technologies - Leading edge precision manufacturing, coatings, innovative optical solutions and cleaning and refurbishment services -
|
Quarters Ended |
|
Years Ended |
||||||||||||||
(Amounts in millions except percentages) |
2021 |
2020 |
Change |
|
2021 |
2020 |
Change |
||||||||||
Sales |
$ |
69.1 |
|
$ |
49.9 |
|
38.5 |
% |
|
$ |
247.3 |
|
$ |
171.2 |
|
44.5 |
% |
Adjusted Segment EBITDA |
$ |
20.9 |
|
$ |
15.4 |
|
35.7 |
% |
|
$ |
73.2 |
|
$ |
47.1 |
|
55.4 |
% |
Adjusted Segment EBITDA Margin |
|
30.2 |
% |
|
30.9 |
% |
|
|
|
29.6 |
% |
|
27.5 |
% |
|
-
Sales increased
38.5% versus the prior-year period driven by strong demand in the semiconductor market and the acquisitions of Alluxa andNxEdge . Excluding the acquisitions and the impact of foreign exchange translation, sales increased16.6% versus the prior-year period. -
Adjusted segment EBITDA increased
35.7% versus the prior-year period, driven primarily by the acquisitions of Alluxa andNxEdge , as well as strong organic sales growth. Excluding the acquisitions and impact of foreign exchange translation, adjusted segment EBITDA increased10.4% compared to the prior-year period.
Engineered Materials - High performance polymer applications and critical pipeline products - GGB and GPT
|
Quarters Ended |
|
Years Ended |
||||||||||||||
(Amounts in millions except percentages) |
2021 |
2020 |
Change |
|
2021 |
2020 |
Change |
||||||||||
Sales |
$ |
68.2 |
|
$ |
73.6 |
|
(7.3 |
)% |
|
$ |
302.4 |
|
$ |
275.0 |
|
10.0 |
% |
Adjusted Segment EBITDA |
$ |
8.9 |
|
$ |
11.4 |
|
(21.9 |
)% |
|
$ |
43.3 |
|
$ |
32.5 |
|
33.2 |
% |
Adjusted Segment EBITDA Margin |
|
13.0 |
% |
|
15.5 |
% |
|
|
|
14.3 |
% |
|
11.8 |
% |
|
-
Sales decreased
7.3% versus the prior-year period driven primarily by the divestitures of the GGB bushing block and CPI businesses, as well as weakness in automotive, which decelerated sharply in the second half of the year due to chip shortages following a strong first half. Excluding divestitures and the impact of foreign exchange translation, sales were flat compared to the prior-year period. -
Adjusted segment EBITDA decreased
21.9% versus the prior-year period, driven primarily by cost headwinds in excess of pricing initiatives. Excluding the GGB bushing block and CPI divestitures and the impact of foreign exchange translation, adjusted segment EBITDA decreased20.2% compared to the prior-year period.
Full Year 2021 Consolidated Results
Sales of
Corporate expenses for 2021 of
Income from continuing operations attributable to
Adjusted EBITDA of
Balance Sheet, Cash Flow and Capital Allocation
The company generated
EnPro ended the fourth quarter with cash of
Quarterly Dividend
On
2022 Guidance
The company expects 2022 revenue growth to be in the low double-digit range, adjusted EBITDA to be in the range of
|
Guidance (as of 2/22/22) |
Revenue Growth |
Low Double-Digits |
Adjusted EBITDA |
|
Adjusted Diluted EPS |
|
|
|
|
Assumptions |
Amortization of Acquisition-Related Intangible Assets* |
|
Depreciation and Other Amortization |
|
Net Interest Expense |
|
Normalized Tax Rate |
|
*Amortization of acquisition-related intangible assets excluded from the calculation of adjusted diluted EPS |
Conference Call, Webcast Information, and Presentations
EnPro will hold a conference call today,
Primary Segment Operating Performance Measure
The primary metric used by management to allocate resources and assess segment performance is adjusted segment EBITDA, which is segment revenue reduced by operating expenses and other costs identifiable with the segment, excluding acquisition and divestiture expenses, restructuring costs, impairment charges, non-controlling interest compensation, amortization of the fair value adjustment to acquisition date inventory, and depreciation and amortization. Expenses not directly attributable to the segments, corporate expenses, net interest expense, gains/losses related to the sale of assets, and income taxes are not included in the computation of adjusted segment EBITDA. Under
Non-GAAP Financial Information
This press release contains financial measures that have not been prepared in conformity with GAAP. They include adjusted income from to continuing operations attributable to
Management believes these non-GAAP metrics are commonly used financial measures for investors to evaluate the company’s operating performance and, when read in conjunction with the company’s consolidated financial statements, present a useful tool to evaluate the company’s ongoing operations and performance from period to period. In addition, these are some of the factors the company uses in internal evaluations of the overall performance of its businesses. Management acknowledges that there are many items that impact a company’s reported results and the adjustments reflected in these non-GAAP measures are not intended to present all items that may have impacted these results. In addition, these non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies.
Forward-Looking Statements and Guidance
Statements in this press release that express a belief, expectation or intention, as well as those that are not historical fact, are forward-looking statements under the Private Securities Litigation Reform Act of 1995. They involve a number of risks and uncertainties that may cause actual events and results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to: impacts from the COVID-19 pandemic and governmental responses to limit the further spread of COVID-19, including impacts on the company’s operations, and the operations and businesses of its customers and vendors, including whether the company’s operations and those of its customers and vendors will continue to be treated as “essential” operations under government orders restricting business activities or, even if so treated, whether site-specific health and safety concerns might otherwise require certain operations to be halted for some period of time; uncertainty with respect to the duration and severity of these impacts from the COVID-19 pandemic, including impacts on the general economy and the markets served by the company’s customers, as well as supply chain disruptions and materials cost increases that are not passed along to our customers; the extent to which the impacts from the COVID-19 pandemic could result in a reduction in demand for the company’s products and services, which could also result in asset impairment charges, including for goodwill; other economic conditions in the markets served by EnPro’s businesses and those of its customers, some of which are cyclical and experience periodic downturns and disruptions, such as disruptions in the pricing of oil and gas; the impact of geopolitical activity on those markets, including the outbreak (or threat of outbreak) of armed hostilities, prices and availability of its raw materials; uncertainties with respect to the company’s ability to achieve anticipated growth within the semiconductor, life sciences, and other technology-enabled markets; the impact of fluctuations in relevant foreign currency exchange rates or unanticipated increases in applicable interest rates; unanticipated delays or problems in introducing new products; the impact of any labor disputes; announcements by competitors of new products, services or technological innovations; changes in pricing policies or the pricing policies of competitors; and the amount of any payments required to satisfy contingent liabilities, including those related to discontinued operations, other divested businesses and the discontinued operations of its predecessors, including liabilities for certain products, environmental matters, employee benefit and statutory severance obligations and other matters. EnPro’s filings with the
Full-year guidance excludes changes in the number of shares outstanding, impacts from future and pending acquisitions, dispositions and related transaction costs, restructuring costs, incremental impacts of tariffs and trade tensions on market demand and costs subsequent to the end of the fourth quarter, the impact of foreign exchange rate changes subsequent to the end of the fourth quarter, increases in interest rates beyond those assumed in the preparation of the guidance, impacts from further spread of COVID-19 or from geopolitical activity, including the outbreak (or threat of outbreak) of armed hostilities, and environmental and litigation charges.
About EnPro
EnPro is an industrial technology company focused on unique applications across many end-markets, including semiconductor, photonics, industrial process, aerospace, food and pharma and life sciences. For more information about EnPro, visit the company’s website at http://www.enproindustries.com.
####
APPENDICES
Consolidated Financial Information and Reconciliations
|
|||||||||||||
Consolidated Statements of Operations (Unaudited) |
|||||||||||||
For the Quarters and Years Ended |
|||||||||||||
(Stated in Millions of Dollars, Except Per Share Data) |
|||||||||||||
|
Quarters Ended |
|
Years Ended |
||||||||||
|
|
|
|
|
|
||||||||
|
2021 |
2020 |
|
2021 |
2020 |
||||||||
Net sales |
$ |
280.8 |
|
$ |
276.0 |
|
|
$ |
1,141.8 |
|
$ |
1,074.0 |
|
Cost of sales |
|
180.1 |
|
|
172.5 |
|
|
|
705.2 |
|
|
698.2 |
|
Gross profit |
|
100.7 |
|
|
103.5 |
|
|
|
436.6 |
|
|
375.8 |
|
Operating expenses: |
|
|
|
|
|
||||||||
Selling, general and administrative |
|
93.3 |
|
|
85.2 |
|
|
|
336.3 |
|
|
299.8 |
|
Other |
|
0.8 |
|
|
7.2 |
|
|
|
6.0 |
|
|
50.1 |
|
Total operating expenses |
|
94.1 |
|
|
92.4 |
|
|
|
342.3 |
|
|
349.9 |
|
Operating income |
|
6.6 |
|
|
11.1 |
|
|
|
94.3 |
|
|
25.9 |
|
Interest expense |
|
(4.3 |
) |
|
(3.9 |
) |
|
|
(16.3 |
) |
|
(16.5 |
) |
Interest income |
|
0.8 |
|
|
0.4 |
|
|
|
2.6 |
|
|
1.6 |
|
Other income (expense) |
|
113.3 |
|
|
(22.3 |
) |
|
|
131.8 |
|
|
(37.8 |
) |
Income (loss) from continuing operations before income taxes |
|
116.4 |
|
|
(14.7 |
) |
|
|
212.4 |
|
|
(26.8 |
) |
Income tax benefit (expense) |
|
(13.7 |
) |
|
5.7 |
|
|
|
(34.8 |
) |
|
3.5 |
|
Income (loss) from continuing operations |
|
102.7 |
|
|
(9.0 |
) |
|
|
177.6 |
|
|
(23.3 |
) |
Income from discontinued operations, including gain on sale, net of taxes |
|
— |
|
|
0.8 |
|
|
|
— |
|
|
208.1 |
|
Net income (loss) |
|
102.7 |
|
|
(8.2 |
) |
|
|
177.6 |
|
|
184.8 |
|
Less: net income (loss) attributable to redeemable non-controlling interests |
|
0.3 |
|
|
(0.1 |
) |
|
|
0.4 |
|
|
0.4 |
|
Net income (loss) attributable to |
$ |
102.4 |
|
$ |
(8.1 |
) |
|
$ |
177.2 |
|
$ |
184.4 |
|
|
|
|
|
|
|
||||||||
Income (loss) attributable to |
|
|
|
|
|
||||||||
Income (loss) from continuing operations, net of tax |
$ |
102.4 |
|
$ |
(8.9 |
) |
|
$ |
177.2 |
|
$ |
(23.7 |
) |
Income from discontinued operations, net of tax |
|
— |
|
|
0.8 |
|
|
|
— |
|
|
208.1 |
|
Net income (loss) attributable to |
$ |
102.4 |
|
$ |
(8.1 |
) |
|
$ |
177.2 |
|
$ |
184.4 |
|
|
|
|
|
|
|
||||||||
Basic earnings (loss) per share attributable to |
|
|
|
|
|
||||||||
Continuing operations |
$ |
4.97 |
|
$ |
(0.43 |
) |
|
$ |
8.60 |
|
$ |
(1.15 |
) |
Discontinued operations |
|
— |
|
|
0.04 |
|
|
|
— |
|
|
10.13 |
|
Basic earnings (loss) per share |
$ |
4.97 |
|
$ |
(0.39 |
) |
|
$ |
8.60 |
|
$ |
8.98 |
|
Average common shares outstanding (millions) |
|
20.6 |
|
|
20.5 |
|
|
|
20.6 |
|
|
20.5 |
|
|
|
|
|
|
|
||||||||
Diluted earnings (loss) per share attributable to |
|
|
|
|
|
||||||||
Continuing operations |
$ |
4.92 |
|
$ |
(0.43 |
) |
|
$ |
8.53 |
|
$ |
(1.15 |
) |
Discontinued operations |
|
— |
|
|
0.04 |
|
|
|
— |
|
|
10.13 |
|
Diluted earnings (loss) per share |
$ |
4.92 |
|
$ |
(0.39 |
) |
|
$ |
8.53 |
|
$ |
8.98 |
|
Average common shares outstanding (millions) |
|
20.8 |
|
|
20.5 |
|
|
|
20.8 |
|
|
20.5 |
|
|
||||||
Consolidated Statements of Cash Flows (Unaudited) |
||||||
For the Years Ended |
||||||
(Stated in Millions of Dollars) |
||||||
|
2021 |
2020 |
||||
Operating activities of continuing operations |
|
|
||||
Net income |
$ |
177.6 |
|
$ |
184.8 |
|
Adjustments to reconcile net income to net cash provided by operating activities of continuing operations: |
|
|
||||
Income from discontinued operations, net of taxes |
|
— |
|
|
(208.1 |
) |
Taxes paid related to sale of discontinued operations |
|
— |
|
|
(38.7 |
) |
Depreciation |
|
27.5 |
|
|
30.2 |
|
Amortization |
|
48.3 |
|
|
40.6 |
|
Loss (gain) on sale of businesses |
|
(135.2 |
) |
|
2.6 |
|
Asset impairments |
|
— |
|
|
29.3 |
|
Deferred income taxes |
|
(5.2 |
) |
|
(14.6 |
) |
Stock-based compensation |
|
5.0 |
|
|
5.4 |
|
Other non-cash adjustments |
|
2.1 |
|
|
3.2 |
|
Change in assets and liabilities, net of effects of acquisitions and divestitures of businesses: |
|
|
||||
Accounts receivable, net |
|
(18.4 |
) |
|
18.7 |
|
Inventories |
|
(13.3 |
) |
|
19.5 |
|
Accounts payable |
|
7.7 |
|
|
0.3 |
|
Other current assets and liabilities |
|
40.6 |
|
|
(30.9 |
) |
Other non-current assets and liabilities |
|
5.3 |
|
|
15.3 |
|
Net cash provided by operating activities of continuing operations |
|
142.0 |
|
|
57.6 |
|
Investing activities of continuing operations |
|
|
||||
Purchases of property, plant and equipment |
|
(18.8 |
) |
|
(18.3 |
) |
Proceeds from sale of businesses |
|
224.3 |
|
|
475.1 |
|
Acquisitions, net of cash acquired |
|
(856.8 |
) |
|
(238.3 |
) |
Other |
|
0.1 |
|
|
(2.4 |
) |
Net cash provided by (used in) investing activities of continuing operations |
|
(651.2 |
) |
|
216.1 |
|
Financing activities of continuing operations |
|
|
||||
Proceeds from debt |
|
715.0 |
|
|
29.9 |
|
Repayments of debt |
|
(79.0 |
) |
|
(168.2 |
) |
Issuance of common stock |
|
10.0 |
|
|
— |
|
Repurchase of common stock |
|
— |
|
|
(5.3 |
) |
Dividends paid |
|
(22.4 |
) |
|
(21.7 |
) |
Other |
|
(5.4 |
) |
|
(2.0 |
) |
Net cash provided by (used in) financing activities of continuing operations |
|
618.2 |
|
|
(167.3 |
) |
Cash flows of discontinued operations |
|
|
||||
Operating cash flows |
|
— |
|
|
(6.2 |
) |
Net cash used in discontinued operations |
|
— |
|
|
(6.2 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(0.4 |
) |
|
8.1 |
|
Net increase in cash and cash equivalents |
|
108.6 |
|
|
108.3 |
|
Cash and cash equivalents at beginning of period |
|
229.5 |
|
|
121.2 |
|
Cash and cash equivalents at end of period |
$ |
338.1 |
|
$ |
229.5 |
|
|
|
|
||||
Supplemental disclosures of cash flow information: |
|
|
||||
Cash paid during the period for: |
|
|
||||
Interest, net |
$ |
14.9 |
|
$ |
16.1 |
|
Income taxes, net |
$ |
6.4 |
|
$ |
67.2 |
|
|
||||||
Consolidated Balance Sheets (Unaudited) |
||||||
As of |
||||||
(Stated in Millions of Dollars) |
||||||
|
2021 |
2020 |
||||
Current assets |
|
|
||||
Cash and cash equivalents |
$ |
338.1 |
|
$ |
229.5 |
|
Accounts receivable, net |
|
177.0 |
|
|
143.2 |
|
Inventories |
|
160.0 |
|
|
139.1 |
|
Income tax receivable |
|
9.7 |
|
|
49.6 |
|
Other current assets |
|
28.2 |
|
|
17.6 |
|
Total current assets |
|
713.0 |
|
|
579.0 |
|
Property, plant and equipment, net |
|
236.7 |
|
|
195.0 |
|
|
|
964.1 |
|
|
621.8 |
|
Other intangible assets |
|
901.4 |
|
|
553.6 |
|
Other assets |
|
153.5 |
|
|
134.2 |
|
Total assets |
$ |
2,968.7 |
|
$ |
2,083.6 |
|
|
|
|
||||
Current liabilities |
|
|
||||
Current maturities of long-term debt |
$ |
12.7 |
|
$ |
3.8 |
|
Short-term debt |
|
149.3 |
|
|
— |
|
Accounts payable |
|
81.9 |
|
|
69.8 |
|
Accrued expenses |
|
135.2 |
|
|
128.4 |
|
Total current liabilities |
|
379.1 |
|
|
202.0 |
|
Long-term debt |
|
963.9 |
|
|
487.5 |
|
Deferred taxes and non-current income taxes payable |
|
166.3 |
|
|
130.5 |
|
Other liabilities |
|
142.7 |
|
|
136.7 |
|
Total liabilities |
|
1,652.0 |
|
|
956.7 |
|
|
|
|
||||
Redeemable non-controlling interests |
|
50.1 |
|
|
48.4 |
|
|
|
|
||||
Shareholders’ equity |
|
|
||||
Common stock |
|
0.2 |
|
|
0.2 |
|
Additional paid-in capital |
|
303.6 |
|
|
289.6 |
|
Retained earnings |
|
949.4 |
|
|
794.8 |
|
Accumulated other comprehensive income (loss) |
|
14.6 |
|
|
(4.9 |
) |
Common stock held in treasury, at cost |
|
(1.2 |
) |
|
(1.2 |
) |
Total shareholders’ equity |
|
1,266.6 |
|
|
1,078.5 |
|
Total liabilities and equity |
$ |
2,968.7 |
|
$ |
2,083.6 |
|
|
|||||||||||||
Segment Information (Unaudited) |
|||||||||||||
For the Quarters and Years Ended |
|||||||||||||
(Stated in Millions of Dollars) |
|||||||||||||
|
|
|
|
|
|
||||||||
Sales |
|
|
|
|
|
||||||||
|
Quarters Ended |
|
Years Ended |
||||||||||
|
|
|
|
||||||||||
|
2021 |
2020 |
|
2021 |
2020 |
||||||||
Sealing Technologies |
$ |
143.9 |
|
$ |
154.7 |
|
|
$ |
599.8 |
|
$ |
636.7 |
|
Advanced Surface Technologies |
|
69.1 |
|
|
49.9 |
|
|
|
247.3 |
|
|
171.2 |
|
Engineered Materials |
|
68.2 |
|
|
73.6 |
|
|
|
302.4 |
|
|
275.0 |
|
|
|
281.2 |
|
|
278.2 |
|
|
|
1,149.5 |
|
|
1,082.9 |
|
Less: intersegment sales |
|
(0.4 |
) |
|
(2.2 |
) |
|
|
(7.7 |
) |
|
(8.9 |
) |
|
$ |
280.8 |
|
$ |
276.0 |
|
|
$ |
1,141.8 |
|
$ |
1,074.0 |
|
|
|
|
|
|
|
||||||||
Income (loss) from continuing operations attributable to |
$ |
102.4 |
|
$ |
(8.9 |
) |
|
$ |
177.2 |
|
$ |
(23.7 |
) |
|
|
|
|
|
|
||||||||
Earnings before interest, income taxes, depreciation, |
|
|
|
|
|
||||||||
amortization and other selected items (Adjusted Segment EBITDA) |
|||||||||||||
|
Quarters Ended |
|
Years Ended |
||||||||||
|
|
|
|
||||||||||
|
2021 |
2020 |
|
2021 |
2020 |
||||||||
Sealing Technologies |
$ |
30.6 |
|
$ |
34.9 |
|
|
$ |
141.4 |
|
$ |
131.0 |
|
Advanced Surface Technologies |
|
20.9 |
|
|
15.4 |
|
|
|
73.2 |
|
|
47.1 |
|
Engineered Materials |
|
8.9 |
|
|
11.4 |
|
|
|
43.3 |
|
|
32.5 |
|
|
$ |
60.4 |
|
$ |
61.7 |
|
|
$ |
257.9 |
|
$ |
210.6 |
|
|
|
|
|
|
|
||||||||
Adjusted Segment EBITDA Margin |
|
|
|
|
|
||||||||
|
Quarters Ended |
|
Years Ended |
||||||||||
|
|
|
|
||||||||||
|
2021 |
2020 |
|
2021 |
2020 |
||||||||
Sealing Technologies |
|
21.3 |
% |
|
22.6 |
% |
|
|
23.6 |
% |
|
20.6 |
% |
Advanced Surface Technologies |
|
30.2 |
% |
|
30.9 |
% |
|
|
29.6 |
% |
|
27.5 |
% |
Engineered Materials |
|
13.0 |
% |
|
15.5 |
% |
|
|
14.3 |
% |
|
11.8 |
% |
|
|
21.5 |
% |
|
22.4 |
% |
|
|
22.6 |
% |
|
19.6 |
% |
|
|
|
|
|
|
||||||||
Reconciliation of Adjusted Segment EBITDA to Income (Loss) from Continuing Operations Attributable to |
|||||||||||||
|
Quarters Ended |
|
Years Ended |
||||||||||
|
|
|
|
||||||||||
|
2021 |
2020 |
|
2021 |
2020 |
||||||||
Adjusted Segment EBITDA |
$ |
60.4 |
|
$ |
61.7 |
|
|
$ |
257.9 |
|
$ |
210.6 |
|
Acquisition and divestiture expenses |
|
— |
|
|
(6.9 |
) |
|
|
(0.4 |
) |
|
(9.6 |
) |
Non-controlling interest compensation allocation1 |
|
(1.2 |
) |
|
(1.3 |
) |
|
|
(5.3 |
) |
|
(2.9 |
) |
Amortization of the fair value adjustment to acquisition date inventory |
|
(4.1 |
) |
|
(3.0 |
) |
|
|
(9.9 |
) |
|
(3.0 |
) |
Restructuring and impairment expense |
|
(0.8 |
) |
|
(6.7 |
) |
|
|
(6.0 |
) |
|
(30.6 |
) |
Depreciation and amortization expense |
|
(19.9 |
) |
|
(19.3 |
) |
|
|
(75.6 |
) |
|
(70.7 |
) |
Corporate expenses |
|
(26.9 |
) |
|
(10.6 |
) |
|
|
(62.9 |
) |
|
(37.9 |
) |
Interest expense, net |
|
(3.5 |
) |
|
(3.5 |
) |
|
|
(13.7 |
) |
|
(14.9 |
) |
Other income (expense), net |
|
112.4 |
|
|
(25.1 |
) |
|
|
128.3 |
|
|
(67.8 |
) |
Income (loss) from continuing operations before income taxes |
|
116.4 |
|
|
(14.7 |
) |
|
|
212.4 |
|
|
(26.8 |
) |
Income tax benefit (expense) |
|
(13.7 |
) |
|
5.7 |
|
|
|
(34.8 |
) |
|
3.5 |
|
Income (loss) from continuing operations |
|
102.7 |
|
|
(9.0 |
) |
|
|
177.6 |
|
|
(23.3 |
) |
Less: net income (loss) attributable to redeemable non-controlling interests |
|
0.3 |
|
|
(0.1 |
) |
|
|
0.4 |
|
|
0.4 |
|
Income (loss) from continuing operations attributable to |
$ |
102.4 |
|
$ |
(8.9 |
) |
|
$ |
177.2 |
|
$ |
(23.7 |
) |
Adjusted Segment EBITDA is total segment revenue reduced by operating expenses and other costs identifiable with the segment, excluding acquisition and divestiture expenses, restructuring and impairment expense, non-controlling interest compensation, amortization of the fair value adjustment to acquisition date inventory, and depreciation and amortization.
Corporate expenses include general corporate administrative costs. Expenses not directly attributable to the segments, corporate expenses, net interest expense, gains/losses related to the sale of assets, and income taxes are not included in the computation of Adjusted Segment EBITDA. The accounting policies of the reportable segments are the same as those for the Company.
1Non-controlling interest compensation allocation represents compensation expense associated with a portion of the rollover equity from the acquisitions of LeanTeq and Alluxa that is subject to reduction for certain types of employment terminations of the LeanTeq and Alluxa sellers and is directly related to the terms of the respective acquisitions. This expense will continue to be recognized as compensation expense over the term of the put and call options associated with the acquisitions unless certain employment terminations have occurred.
|
||||||||
Adjusted Segment EBITDA Reconciling Items by Segment (Unaudited) |
||||||||
For the Quarters and Years Ended |
||||||||
(Stated in Millions of Dollars) |
||||||||
|
Quarter Ended |
|||||||
|
Sealing
|
Advanced
|
Engineered
|
Total
|
||||
Non-controlling interest compensation allocation1 |
$ |
— |
$ |
1.2 |
$ |
— |
$ |
1.2 |
Amortization of the fair value adjustment to acquisition date inventory |
$ |
— |
$ |
4.1 |
$ |
— |
$ |
4.1 |
Restructuring and impairment expense |
$ |
0.6 |
$ |
— |
$ |
0.2 |
$ |
0.8 |
Depreciation and amortization expense |
$ |
7.3 |
$ |
9.7 |
$ |
2.9 |
$ |
19.9 |
|
Quarter Ended |
|||||||
|
Sealing
|
Advanced
|
Engineered
|
Total
|
||||
Acquisition and divestiture expenses |
$ |
0.6 |
$ |
6.3 |
$ |
— |
$ |
6.9 |
Non-controlling interest compensation allocation1 |
$ |
— |
$ |
1.3 |
$ |
— |
$ |
1.3 |
Amortization of the fair value adjustment to acquisition date inventory |
$ |
— |
$ |
3.0 |
$ |
— |
$ |
3.0 |
Restructuring and impairment expense |
$ |
1.3 |
$ |
— |
$ |
5.4 |
$ |
6.7 |
Depreciation and amortization expense |
$ |
8.8 |
$ |
6.7 |
$ |
3.8 |
$ |
19.3 |
|
Year Ended |
|||||||
|
Sealing
|
Advanced
|
Engineered
|
Total
|
||||
Acquisition and divestiture expenses |
$ |
0.4 |
$ |
— |
$ |
— |
$ |
0.4 |
Non-controlling interest compensation allocation1 |
$ |
— |
$ |
5.3 |
$ |
— |
$ |
5.3 |
Amortization of the fair value adjustment to acquisition date inventory |
$ |
— |
$ |
9.9 |
$ |
— |
$ |
9.9 |
Restructuring and impairment expense |
$ |
2.4 |
$ |
— |
$ |
3.6 |
$ |
6.0 |
Depreciation and amortization expense |
$ |
30.6 |
$ |
32.9 |
$ |
12.1 |
$ |
75.6 |
|
Year Ended |
|||||||
|
Sealing
|
Advanced
|
Engineered
|
Total
|
||||
Acquisition and divestiture expenses |
$ |
2.8 |
$ |
6.8 |
$ |
— |
$ |
9.6 |
Non-controlling interest compensation allocation1 |
$ |
— |
$ |
2.9 |
$ |
— |
$ |
2.9 |
Amortization of the fair value adjustment to acquisition date inventory |
$ |
— |
$ |
3.0 |
$ |
— |
$ |
3.0 |
Restructuring and impairment expense |
$ |
14.2 |
$ |
0.1 |
$ |
16.3 |
$ |
30.6 |
Depreciation and amortization expense |
$ |
36.5 |
$ |
20.0 |
$ |
14.2 |
$ |
70.7 |
1Non-controlling interest compensation allocation represents compensation expense associated with a portion of the rollover equity from the acquisitions of LeanTeq and Alluxa that is subject to reduction for certain types of employment terminations of the LeanTeq and Alluxa sellers and is directly related to the terms of the respective acquisitions. This expense will continue to be recognized as compensation expense over the term of the put and call options associated with the acquisitions unless certain employment terminations have occurred.
|
||||||||||||||
Reconciliation of Income (Loss) from Continuing Operations Attributable to |
||||||||||||||
For the Quarters and Years Ended |
||||||||||||||
(Stated in Millions of Dollars, Except Per Share Data) |
||||||||||||||
|
Quarters Ended |
|||||||||||||
|
2021 |
|
2020 |
|||||||||||
|
$ |
Average
|
Per
|
|
$ |
Average
|
Per
|
|||||||
Income (loss) from continuing operations attributable to |
$ |
102.4 |
|
20.8 |
$ |
4.92 |
|
$ |
(8.9 |
) |
20.5 |
$ |
(0.43 |
) |
Net income (loss) from redeemable non-controlling interests |
|
0.3 |
|
|
|
|
|
(0.1 |
) |
|
|
|||
Income tax expense (benefit) |
|
13.7 |
|
|
|
|
|
(5.7 |
) |
|
|
|||
Income (loss) from continuing operations before income taxes |
|
116.4 |
|
|
|
|
|
(14.7 |
) |
|
|
|||
|
|
|
|
|
|
|
|
|||||||
Adjustments from selling, general, and administrative: |
|
|
|
|
|
|
|
|||||||
Acquisition and divestiture expenses |
|
15.0 |
|
|
|
|
|
6.7 |
|
|
|
|||
Non-controlling interest compensation allocations1 |
|
1.2 |
|
|
|
|
|
1.3 |
|
|
|
|||
Amortization of acquisition-related intangible assets |
|
12.7 |
|
|
|
|
|
10.9 |
|
|
|
|||
Adjustments from other operating expense and cost of sales: |
|
|
|
|
|
|
|
|||||||
Restructuring and impairment expense |
|
0.8 |
|
|
|
|
|
6.7 |
|
|
|
|||
Amortization of the fair value adjustment to acquisition date inventory |
|
4.1 |
|
|
|
|
|
3.0 |
|
|
|
|||
Legal settlement - legacy matter |
|
— |
|
|
|
|
|
0.1 |
|
|
|
|||
Adjustments from other non-operating expense (income): |
|
|
|
|
|
|
|
|||||||
Environmental reserve adjustment |
|
3.8 |
|
|
|
|
|
22.1 |
|
|
|
|||
Costs (refunds) associated with previously disposed businesses |
|
(0.3 |
) |
|
|
|
|
0.6 |
|
|
|
|||
Net loss (gain) on sale of businesses |
|
(117.6 |
) |
|
|
|
|
0.6 |
|
|
|
|||
Pension income (non-service cost) |
|
(2.2 |
) |
|
|
|
|
(1.0 |
) |
|
|
|||
Tax indemnification asset 2 |
|
3.0 |
|
|
|
|
|
— |
|
|
|
|||
Other adjustments: |
|
|
|
|
|
|
|
|||||||
Other |
|
— |
|
|
|
|
|
(0.1 |
) |
|
|
|||
Adjusted income from continuing operations before income taxes |
|
36.9 |
|
|
|
|
|
36.2 |
|
|
|
|||
Adjusted income tax expense |
|
(11.1 |
) |
|
|
|
|
(10.9 |
) |
|
|
|||
Net loss (income) from redeemable non-controlling interests |
|
(0.3 |
) |
|
|
|
|
0.1 |
|
|
|
|||
Adjusted income from continuing operations attributable to |
$ |
25.5 |
|
20.8 |
$ |
1.23 3 |
|
$ |
25.4 |
|
20.6 4 |
$ |
1.24 3 |
|
|
Years Ended |
|||||||||||||
|
2021 |
|
2020 |
|||||||||||
|
$ |
Average
|
Per
|
|
$ |
Average
|
Per
|
|||||||
Income (loss) from continuing operations attributable to |
$ |
177.2 |
|
20.8 |
$ |
8.53 |
|
$ |
(23.7 |
) |
20.5 |
$ |
(1.15 |
) |
Net income from redeemable non-controlling interests |
|
0.4 |
|
|
|
|
|
0.4 |
|
|
|
|||
Income tax expense (benefit) |
|
34.8 |
|
|
|
|
|
(3.5 |
) |
|
|
|||
Income (loss) from continuing operations before income taxes |
|
212.4 |
|
|
|
|
|
(26.8 |
) |
|
|
|||
|
|
|
|
|
|
|
|
|||||||
Adjustments from selling, general, and administrative: |
|
|
|
|
|
|
|
|||||||
Acquisition and divestiture expenses |
|
17.1 |
|
|
|
|
|
11.2 |
|
|
|
|||
Non-controlling interest compensation allocations1 |
|
5.3 |
|
|
|
|
|
2.9 |
|
|
|
|||
Amortization of acquisition-related intangible assets |
|
46.4 |
|
|
|
|
|
37.8 |
|
|
|
|||
Adjustments from other operating expense and cost of sales: |
|
|
|
|
|
|
|
|||||||
Restructuring and impairment expense |
|
6.2 |
|
|
|
|
|
30.6 |
|
|
|
|||
Amortization of the fair value adjustment to acquisition date inventory |
|
9.9 |
|
|
|
|
|
3.0 |
|
|
|
|||
Impairment of indefinite-lived trademarks |
|
— |
|
|
|
|
|
16.1 |
|
|
|
|||
Legal settlement - legacy matter |
|
— |
|
|
|
|
|
7.5 |
|
|
|
|||
Adjustments from other non-operating expense: |
|
|
|
|
|
|
|
|||||||
Environmental reserve adjustment |
|
8.3 |
|
|
|
|
|
36.2 |
|
|
|
|||
Costs associated with previously disposed businesses |
|
0.4 |
|
|
|
|
|
2.0 |
|
|
|
|||
Net loss (gain) on sale of businesses |
|
(135.2 |
) |
|
|
|
|
2.6 |
|
|
|
|||
Pension income (non-service cost) |
|
(8.3 |
) |
|
|
|
|
(3.0 |
) |
|
|
|||
Tax indemnification asset 2 |
|
3.0 |
|
|
|
|
|
— |
|
|
|
|||
Other adjustments: |
|
|
|
|
|
|
|
|||||||
Other |
|
(0.2 |
) |
|
|
|
|
0.3 |
|
|
|
|||
Adjusted income from continuing operations before income taxes |
|
165.3 |
|
|
|
|
|
120.4 |
|
|
|
|||
Adjusted income tax expense |
|
(49.6 |
) |
|
|
|
|
(36.1 |
) |
|
|
|||
Net income from redeemable non-controlling interests |
|
(0.4 |
) |
|
|
|
|
(0.4 |
) |
|
|
|||
Adjusted income from continuing operations attributable to |
$ |
115.3 |
|
20.8 |
$ |
5.55 3 |
|
$ |
83.9 |
|
20.6 4 |
$ |
4.07 3 |
|
Management of the Company believes that it would be helpful to the readers of the financial statements to understand the impact of certain selected items on the Company's reported income from continuing operations attributable to
Management acknowledges that there are many items that impact a company's reported results and this list is not intended to present all items that may have impacted these results.
Other adjustments are included in selling, general, and administrative, cost of sales, and other operating expenses on the consolidated statements of operations.
The adjusted income tax expense presented above is calculated using a normalized company-wide effective tax rate excluding discrete items of
1Non-controlling interest compensation allocation represents compensation expense associated with a portion of the rollover equity from the acquisitions of LeanTeq and Alluxa that is subject to reduction for certain types of employment terminations of the LeanTeq and Alluxa sellers and is directly related to the terms of the respective acquisitions. This expense will continue to be recognized as compensation expense over the term of the put and call options associated with the acquisitions unless certain employment terminations have occurred.
2 In connection with the acquisition of Aseptic in 2019, we recognized a liability for uncertain tax positions and a related indemnification asset for the portion of that liability recoverable from the seller. We determined the statute of limitations expired on some of the uncertain tax positions in 2021 and, accordingly, removed a portion of the liability and receivable. The release of the related liability was recorded as part of our tax expense for the year ended
3Adjusted diluted earnings per share.
4There were 0.1 million potentially dilutive shares that were excluded from the computation of diluted earnings per share for the quarter and year ended
|
|||||||||||||
Reconciliation of Income (Loss) from Continuing Operations Attributable to |
|||||||||||||
For the Quarters and Years Ended |
|||||||||||||
(Stated in Millions of Dollars) |
|||||||||||||
|
Quarters Ended |
|
Years Ended |
||||||||||
|
|
|
|
||||||||||
|
2021 |
2020 |
|
2021 |
2020 |
||||||||
Income (loss) from continuing operations attributable to |
$ |
102.4 |
|
$ |
(8.9 |
) |
|
$ |
177.2 |
|
$ |
(23.7 |
) |
Net income (loss) attributable to redeemable non-controlling interests |
|
0.3 |
|
|
(0.1 |
) |
|
|
0.4 |
|
|
0.4 |
|
Income (loss) from continuing operations |
|
102.7 |
|
|
(9.0 |
) |
|
|
177.6 |
|
|
(23.3 |
) |
|
|
|
|
|
|
||||||||
Adjustments to arrive at earnings from continuing operations before interest, income taxes, depreciation, amortization, and other selected items (Adjusted EBITDA): |
|
|
|
|
|
||||||||
Interest expense, net |
|
3.5 |
|
|
3.5 |
|
|
|
13.7 |
|
|
14.9 |
|
Income tax expense (benefit) |
|
13.7 |
|
|
(5.7 |
) |
|
|
34.8 |
|
|
(3.5 |
) |
Depreciation and amortization expense |
|
20.0 |
|
|
19.3 |
|
|
|
75.8 |
|
|
70.8 |
|
Restructuring and impairment expense |
|
0.8 |
|
|
6.7 |
|
|
|
6.2 |
|
|
30.6 |
|
Environmental reserve adjustments |
|
3.8 |
|
|
22.1 |
|
|
|
8.3 |
|
|
36.2 |
|
Costs (refunds) associated with previously disposed businesses |
|
(0.3 |
) |
|
0.6 |
|
|
|
0.4 |
|
|
2.0 |
|
Net loss (gain) on sale of businesses |
|
(117.6 |
) |
|
0.6 |
|
|
|
(135.2 |
) |
|
2.6 |
|
Acquisition and divestiture expenses |
|
15.0 |
|
|
6.7 |
|
|
|
17.1 |
|
|
11.2 |
|
Pension income (non-service cost) |
|
(2.2 |
) |
|
(1.0 |
) |
|
|
(8.3 |
) |
|
(3.0 |
) |
Non-controlling interest compensation allocation1 |
|
1.2 |
|
|
1.3 |
|
|
|
5.3 |
|
|
2.9 |
|
Impairment of indefinite-lived trademarks |
|
— |
|
|
— |
|
|
|
— |
|
|
16.1 |
|
Legal settlement - legacy matter |
|
— |
|
|
0.1 |
|
|
|
— |
|
|
7.5 |
|
Amortization of the fair value adjustment to acquisition date inventory |
|
4.1 |
|
|
3.0 |
|
|
|
9.9 |
|
|
3.0 |
|
Tax indemnification asset 2 |
|
3.0 |
|
|
— |
|
|
|
3.0 |
|
|
— |
|
Other |
|
— |
|
|
(0.1 |
) |
|
|
(0.2 |
) |
|
0.3 |
|
Adjusted EBITDA |
$ |
47.7 |
|
$ |
48.1 |
|
|
$ |
208.4 |
|
$ |
168.3 |
|
1Non-controlling interest compensation allocation represents compensation expense associated with a portion of the rollover equity from the acquisitions of LeanTeq and Alluxa that is subject to reduction for certain types of employment terminations of the LeanTeq and Alluxa sellers and is directly related to the terms of the respective acquisitions. This expense will continue to be recognized as compensation expense over the term of the put and call options associated with the acquisitions unless certain employment terminations have occurred.
2 In connection with the acquisition of Aseptic in 2019, we recognized a liability for uncertain tax positions and a related indemnification asset for the portion of that liability recoverable from the seller. We determined the statute of limitations expired on some of the uncertain tax positions in 2021 and, accordingly, removed a portion of the liability and receivable. The release of the related liability was recorded as part of our tax expense for the year ended
Supplemental disclosure: Adjusted EBITDA as presented also represents the amount defined as "EBITDA" under the indenture governing the Company's
|
|||
Reconciliation of Free Cash Flow (Unaudited) |
|||
(Stated in Millions of Dollars) |
|||
|
|
||
Free Cash Flow - Year Ended |
|||
Net cash provided by operating activities of continuing operations |
$ |
142.0 |
|
Purchases of property, plant, and equipment |
|
(18.8 |
) |
Free cash flow |
$ |
123.2 |
|
|
|
||
Free Cash Flow - Year Ended |
|||
Net cash provided by operating activities of continuing operations |
$ |
57.6 |
|
Purchases of property, plant, and equipment |
|
(18.3 |
) |
Free cash flow |
$ |
39.3 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220222005418/en/
Investor Contacts:
Executive Vice President and
Chief Financial Officer
Vice President, Investor Relations
Phone: 704-731-1527
Email: investor.relations@enproindustries.com
Source:
FAQ
What were EnPro Industries' fourth quarter 2021 sales?
What is EnPro's expected revenue growth for 2022?
How did EnPro's income from continuing operations change in Q4 2021?
What was the diluted earnings per share for EnPro in Q4 2021?